Displaying 69 Amsterdam Biotech companies
 Filter
City
Country
Stage
Business Model
Industry
Clear All
Export
Amsterdam Netherlands Biotech All business models
company score funding investors employees industries biz model city contact
Flindr TherapeuticsJUST ADDED HIRING

Precision oncology treatments developer.
64
$21M · Series A V-Bio Ventures 1 to 10 Health Tech, Biotech Amsterdam, Netherlands •••••••••••@flindrtx.com
Farmless

Fermentation process to produce protein from animals.
54
$5M · Seed Voyager Ventures, Revent, World Fund 1 to 10 Foodtech, Biotech B2C Amsterdam, Netherlands •••••••••••@farmless.com
Paques Biomaterials

Polyhydroxyalkanoates (PHA) producer.
54
$15M · Seed NV NOM, Invest-NL 1 to 10 Biotech Amsterdam, Netherlands •••••••••••@paquesbiomaterials.nl
Tessellate BIO

Precision oncology researcher.
50
$8M · Seed BioGeneration Ventures, Forbion Capital Partners 11 to 50 Health Tech, Biotech Amsterdam, Netherlands •••••••••••@tessellatebio.com
Leyden Labs

Manufacturer of medicines to protect from the threat of respiratory viruses
50
$47M GV, SoftBank Group 11 to 50 Health Tech, Biotech, Deep Tech B2B Amsterdam, Netherlands •••••••••••@leydenlabs.com
NorthSea Therapeutics

Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
50
$27M · Series A Sofinnova Partners, Novo A/S, Forbion Capital Partners 11 to 50 Health Tech, Biotech B2B Amsterdam, Netherlands •••••••••••@northseatherapeutics.com
VectorY

Antibody therapeutics treatment for neurodegenerative diseases.
50
$33M · Seed Benhamou Global Ventures, Insight Venture Partners, MRL Ventures Fund 51 to 200 Health Tech, Biotech Amsterdam, Netherlands •••••••••••@vectorytx.com
Scenic Biotech

Developer of genomics and immunotherapy technology.
43
$7M · Series A BioMedPartners, Vesalius Biocapital Partners, Inkef Capital 11 to 50 Health Tech, Biotech, Deep Tech, Manufacturing B2B Amsterdam, Netherlands •••••••••••@scenicbiotech.com
CimCure

Platform focused on designing and developing new active cancer immunotherapies.
43
$5M · Seed Positron Ventures Health Tech, Biotech, Pharma B2B Amsterdam, Netherlands •••••••••••@cimcure.com
Castor EDC

Cloud-based clinical data platform.
43
$6M · Seed Eight Roads Ventures, Inkef Capital 101 to 250 Health Tech, Biotech, Pharma B2B, SaaS Amsterdam, Netherlands •••••••••••@castoredc.com
Gilbert Technologies

Inhalers for lung problems.
43
$4M · Series A DeepTechXL 1 to 10 Health Tech, Biotech Amsterdam, Netherlands •••••••••••@gilberttechnologies.eu
LUMICKS

Single-molecule and cell avidity analysis platform.
34
$92M · Series D 51 to 100 Biotech, Deep Tech Amsterdam, Netherlands •••••••••••@lumicks.com
Nostics

Diagnostics platform delivers speedier test results using advanced algorithms.
34
$350k · Pre Seed Dutch Founders Fund 11 to 50 Health Tech, Biotech B2C Amsterdam, Netherlands •••••••••••@nostics.com
RheoCube

Platform for simulating complex fluids in the cloud with a user-friendly interface.
34
$2M Join Capital 11 to 50 Biotech, Developer Tools, Cloud B2B, SaaS Amsterdam, Netherlands •••••••••••@rheocube.com
NextKidney

Portable hemodialysis device.
28
$12M · Series B 11 to 50 Biotech Amsterdam, Netherlands •••••••••••@nextkidney.com
Neogene Therapeutics

Neo-antigen T cell therapies developer to treat cancer.
28
$15M · Series A 11 to 50 Health Tech, Biotech B2B Amsterdam, Netherlands •••••••••••@neogene.com
Avantium

Platform supplying high-throughput research and development technologies for the energy, chemicals, and pharmaceutical industries.
15
N/A 51 to 100 Biotech, Deep Tech Amsterdam, Netherlands •••••••••••@avantium.com
Braingineers

Combining Neuroscience & Machine Learning in an Emotion Analytics platform
15
N/A 11 to 50 Biotech, Data and Analytics Amsterdam, Netherlands •••••••••••@braingineers.com
Kiadis Pharma

Biopharmaceutical company offering novel treatment options for terminally ill cancer patients.
15
N/A 11 to 50 Biotech, Deep Tech Amsterdam, Netherlands •••••••••••@kiadis.com
Serda TherapeuticsJUST ADDED HIRING

Developer of enzymatic wound debridement product for burns and ulcers.
1
$2M · Seed NLC 1 to 10 Health Tech, Biotech B2C Amsterdam, Netherlands •••••••••••@serda-therapeutics.com
AdcytherixJUST ADDED

Antibody drug conjugates (ADC) developer.
1
N/A 1 to 10 Health Tech, Biotech Amsterdam, Netherlands •••••••••••@adcytherix.com